{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:15Z","timestamp":1740147315678,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Epistaxis represents a massive burden upon NHS resources. Despite being an extremely common reason for emergency ENT admissions, there remains significant variation in its management. Although the evidence base is continually growing, there appears to be a lack of guidance towards managing anti-coagulants and anti-platelet medications and identifying patient-specific outcomes in this setting. Epistaxis has long been associated with a multitude of risk factors but none have shown consistent, direct correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>We aimed to identify if the use of anti-thrombotic medication was associated with a longer length of hospital admission or conferred a higher requirement for nasal packing, re-packing, surgery or re-admission. We conducted a retrospective analysis of 100 consecutive adult patients admitted over a 6-month period. Statistical analysis was conducted using SPSS software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty-five percent of patients were taking anti-thrombotic medication. The variability of admission INR values in those taking warfarin did not relate with any outcome measure. There was no statistical difference between patients taking anti-thrombotic medication and those who do not, with regards to our primary outcome measures. Re-admission rates within 28\u00a0days were found to be 13%, with anti-thrombotic medication use and pre-existing cardiovascular disease recognised as commonly encountered risk factors. Three percent of patients required surgical intervention. Eight percent of patients required re-packing, with a Rapid Rhino chosen in all instances.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The use of anti-thrombotic medication is not associated with increased morbidity or increased rate of complications. Anti-thrombotic usage and more than one medical co-morbidity increase the risk of re-admission within 28\u00a0days.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-021-02790-1","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T05:02:26Z","timestamp":1632546146000},"page":"1621-1629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-thrombotics and their impact on inpatient epistaxis management: a tertiary centre experience"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1496-070X","authenticated-orcid":false,"given":"Gavin","family":"Donaldson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwee Yen","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghav C.","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"issue":"5","key":"2790_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1749-4486.2007.01530.x","volume":"32","author":"TW Walker","year":"2007","unstructured":"Walker TW, MacFarlane TV, McGarry GW (2007) The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995\u20132004. Clin Otolaryngol 32(5):361\u2013365","journal-title":"Clin Otolaryngol"},{"key":"2790_CR2","unstructured":"(2017) NHS Hospital Episode Statistics in England and Wales.\u00a0http:\/\/www.hesonline.nhs.uk"},{"issue":"2","key":"2790_CR3","first-page":"305","volume":"71","author":"CJ Kucik","year":"2005","unstructured":"Kucik CJ, Clenney T (2005) Management of epistaxis. Am Fam Physician 71(2):305\u2013311","journal-title":"Am Fam Physician"},{"issue":"6","key":"2790_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1749-4486.2008.01795.x","volume":"33","author":"A Daudia","year":"2008","unstructured":"Daudia A, Jaiswal V, Jones NS (2008) Guidelines for the management of idiopathic epistaxis in adults: how we do it. Clin Otolaryngol 33(6):618\u2013620","journal-title":"Clin Otolaryngol"},{"issue":"955","key":"2790_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/pgmj.2004.025007","volume":"81","author":"L Pope","year":"2005","unstructured":"Pope L, Hobbs C (2005) Epistaxis: an update on current management. Postgrad Med J 81(955):309\u2013314","journal-title":"Postgrad Med J"},{"issue":"8","key":"2790_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMcp0807078","volume":"360","author":"RJ Schlosser","year":"2009","unstructured":"Schlosser RJ (2009) Epistaxis. N Engl J Med 360(8):784\u2013789","journal-title":"N Engl J Med"},{"key":"2790_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00405-008-0657-1","volume":"265","author":"T Upile","year":"2008","unstructured":"Upile T, Jerjes W, Sipaul F et al (2008) A change in UK epistaxis management. Eur Arch Otorhinolaryngol 265:1349\u20131354","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2790_CR8","doi-asserted-by":"crossref","unstructured":"Kikidis D, Tsioufis K, Papanikolaou V et al (2014)\u00a0Is epistaxis associated with arterial hypertension? A systematic review of the literature. Eur Arch Otorhinolaryngol 271(2):237\u2013243","DOI":"10.1007\/s00405-013-2450-z"},{"issue":"3","key":"2790_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.anl.2017.07.021","volume":"45","author":"Corte","year":"2018","unstructured":"Corte et al (2018) Risk factors for the occurrence of epistaxis: Prospective study. Auris Nasus Larynx 45(3):471\u2013475","journal-title":"Auris Nasus Larynx"},{"key":"2790_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/S002221511700202X","volume":"131","author":"INTEGRATE (THE NATIONAL ENT TRAINEE","year":"2017","unstructured":"INTEGRATE (THE NATIONAL ENT TRAINEE RESEARCH NETWORK). (2017) Epistaxis 2016: national audit of management. J Laryngol Otol 131:1131\u20131141","journal-title":"J Laryngol Otol"},{"key":"2790_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1017\/S0022215117002031","volume":"131","author":"M Khan","year":"2017","unstructured":"Khan M, Conroy K, Ubayasiri K et al (2017) Initial assessment in the management of adult epistaxis: systematic review. J Laryngol Otol 131:1035\u20131055","journal-title":"J Laryngol Otol"},{"issue":"3","key":"2790_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/HPC.0000000000000139","volume":"17","author":"Conti","year":"2018","unstructured":"Conti et al (2018) Role of hypertension and other clinical variables in prognostication of patients presenting to the emergency department with major bleeding events. Crit Pathw Cardiol 17(3):139\u2013146","journal-title":"Crit Pathw Cardiol"},{"key":"2790_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1017\/S002221511700038X","volume":"131","author":"N Mehta","year":"2017","unstructured":"Mehta N, Williams RJ, Smith ME et al (2017) Can trainees design and deliver a national audit of epistaxis management? A pilot of a secure web-based audit tool and research trainee collaboratives. J Laryngol Otol 131:518\u2013522","journal-title":"J Laryngol Otol"},{"issue":"9","key":"2790_CR14","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/bcp.13299","volume":"83","author":"S Loo","year":"2017","unstructured":"Loo S, Dell\u2019Aniello S, Huiart L, Renoux C (2017) Trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol 83(9):2096","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2790_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jamaoto.2013.5220","volume":"139","author":"JA Villcock","year":"2013","unstructured":"Villcock JA, Jones K (2013) Recent trends in epistaxis management in the United States 2008\u20132010. JAMA Otolaryngol Head Neck Surg 139(12):1279\u20131284","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"2790_CR16","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/lary.25374","volume":"125","author":"E Goljo","year":"2015","unstructured":"Goljo E, Dang R, Iloreta A, Govindaraj S (2015) Cost of management in epistaxis admission: impact of patient and hospital characteristics. Laryngoscope 125(12):2642\u20137","journal-title":"Laryngoscope"},{"key":"2790_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/coa.12904","volume":"43","author":"TC Sauter","year":"2018","unstructured":"Sauter TC, Hegazy K, Hautz WE et al (2018) Epistaxis in anticoagulated patients: fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon. Clin Otolaryngol 43:103\u2013108","journal-title":"Clin Otolaryngol"},{"key":"2790_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2482-7-19","volume":"7","author":"T Upile","year":"2007","unstructured":"Upile T, Jerjes SF et al (2007) The role of surgical audit in improving patient management; nasal haemorrhage: an audit study. BMC Surg 7:19","journal-title":"BMC Surg"},{"key":"2790_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1017\/S0022215106003148","volume":"121","author":"FC Van Wyk","year":"2007","unstructured":"Van Wyk FC, Massey S, Worley G, Brady S (2007) Do all epistaxis patients with a nasal pack need admission? A retrospective study of 116 patients managed in accident and emergency according to a peer reviewed protocol. J Laryngol Otol 121:222\u2013227","journal-title":"J Laryngol Otol"},{"key":"2790_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1017\/S0022215115000596","volume":"129","author":"AC Hall","year":"2015","unstructured":"Hall AC, Blanchford H, Chatrath, Hopkins C (2015) A multi-centre audit of epistaxis management in England: is there a case for a national review of practice? J Laryngol Otol 129:454\u2013457","journal-title":"J Laryngol Otol"},{"key":"2790_CR21","first-page":"1","volume":"2236","author":"FC Corte","year":"2017","unstructured":"Corte FC, Orfao T, Dias CC et al (2017) Risk factors for the occurrence of epistaxis: prospective study. Auris Nasus Larynx 2236:1\u20135","journal-title":"Auris Nasus Larynx"},{"key":"2790_CR22","unstructured":"(2012) NHS Hospital Episode Statistics in England and Wales 2011\u20132012.\u00a0http:\/\/hesonline.nhs.uk"},{"issue":"6","key":"2790_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/coa.13178","volume":"43","author":"C Douglas","year":"2018","unstructured":"Douglas C, Tikka T, Broadbent B et al (2018) Patterns of hospital admission in 54, 501 patients with epistaxis over a 20-year period in Scotland, UK. Clin Otolaryngol 43(6):1465\u20131470","journal-title":"Clin Otolaryngol"},{"key":"2790_CR24","doi-asserted-by":"publisher","first-page":"h2391","DOI":"10.1136\/bmj.h2391","volume":"351","author":"PR Daniels","year":"2015","unstructured":"Daniels PR (2015) Peri-procedural management of patients taking oral anticoagulants. BMJ 351:h2391","journal-title":"BMJ"},{"key":"2790_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S0022215100122613","volume":"107","author":"SW Denholm","year":"1993","unstructured":"Denholm SW, Maynard CA, Watson HG (1993) Warfarin and epistaxis- a case-controlled study. J Laryngol Otol 107:195\u2013196","journal-title":"J Laryngol Otol"},{"key":"2790_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S0022215110001921","volume":"125","author":"J Smith","year":"2011","unstructured":"Smith J, Siddiq, Dyer C et al (2011) Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study. J Laryngol Otol 125:38\u201342","journal-title":"J Laryngol Otol"},{"key":"2790_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1017\/S0022215117002067","volume":"131","author":"A Williams","year":"2017","unstructured":"Williams A, Biffen A, Pilkington N et al (2017) Haematological factors in the management of adult epistaxis: systematic review. J Laryngol Otol 131:1093\u20131107","journal-title":"J Laryngol Otol"},{"key":"2790_CR28","first-page":"542","volume":"22","author":"V Srinivasan","year":"1997","unstructured":"Srinivasan V, Patel H, John DG, Worsley A (1997) Warfarin and epistaxis: should warfarin always be discontinued? Clin Otolaryngol 22:542\u2013544","journal-title":"Clin Otolaryngol"},{"key":"2790_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/000348949810700808","volume":"107","author":"HL Tay","year":"1998","unstructured":"Tay HL, McMahon AD, Evans JM, MacDonald TM (1998) Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study. Ann Otol Rhinol Laryngol 107:671\u20134","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2790_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1749-4486.2009.01926.x","volume":"34","author":"JW Rainsbury","year":"2009","unstructured":"Rainsbury JW, Molony NC (2009) Clopidogrel versus low-dose aspirin as risk factors for epistaxis. Clin Otolaryngol 34:232\u2013235","journal-title":"Clin Otolaryngol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02790-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02790-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02790-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T02:10:08Z","timestamp":1658628608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02790-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2790"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02790-1","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"30 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was not required in the completion of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}